Psychogenic facial pain. Part 2: Management and prognosis.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D003988:Dibenzothiepins / Q000627:therapeutic use*; D004308:Dothiepin / Q000627:therapeutic use*; D004311:Double-Blind Method; D005145:Face; D006801:Humans; D008875:Middle Aged; D009064:Mouth Protectors; D010146:Pain / Q000188:drug therapy* / Q000523:psychology; D059408:Pain Management; D010919:Placebos; D011379:Prognosis; D011602:Psychophysiologic Disorders / Q000188:drug therapy* / Q000628:therapy
D003988:Dibenzothiepins; D010919:Placebos; D004308:Dothiepin